Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X

Tolero enrols first patient in Phase Ib/II trial of alvocidib

Enlarged spleen due to myelodysplastic syndrome. Credit: Tdvorak.

  • Tumour

Go Top